Patrick Kennedy is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 6,702 shares of JAZZ, which is worth approximately $934,794. The most recent transaction as insider was on Aug 08, 2025, when has been sold 1,959 shares (Ordinary Shares) at a price of $111.25 per share, resulting in proceeds of $217,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.7K
30.03% 3M change
30.03% 12M change
Total Value Held $934,794

Patrick Kennedy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2025
SELL
Payment of exercise price or tax liability
$217,938 $111.25 p/Share
1,959 Reduced 22.62%
6,702 Ordinary Shares
Aug 07 2025
BUY
Grant, award, or other acquisition
-
3,507 Added 28.82%
8,661 Ordinary Shares
Aug 02 2024
BUY
Grant, award, or other acquisition
-
3,731 Added 41.99%
5,154 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
1,423 Added 50.0%
1,423 Common Stock
PK

Patrick Kennedy

Director
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ